Marilla Capital ICAV (CLONE) - Central Bank of Ireland Issues Warning on Unauthorised Firm
RegCanary analysis of a CBI publication
Why it matters
RegCanary's analysis of what this means for regulated firms.
For compliance teams, this is a reminder that clone entities can misuse legitimate-looking corporate structures to solicit investors or counterparties. Although the warning does not impose new rules on authorised firms, it raises immediate operational and reputational risk for any institution whose clients, staff or service providers may encounter the clone. Firms should confirm that no business relationship exists, screen onboarding pipelines, and check whether the entity is using the name, registration details or branding of an authorised firm.
Actions: verify against CBI registers; escalate suspicious approaches; refresh clone-firm detection in KYC/EDD and third-party risk processes; issue client/staff alerts where exposure is plausible; preserve evidence and report to the CBI and An Garda Síochána. This is an opportunity to demonstrate robust investor protection and fraud controls, but failure to act could lead to client harm, regulatory scrutiny and reputational damage.
Who this affects
Sectors and firm types identified in the analysis.
- General Regulation
Source
CBI
Original publication, 15 October 2026
Read the original publication centralbank.ieThis is RegCanary's analysis, not the regulator's text. It summarises and interprets the publication above; it is not the CBI's original wording, and it is not legal advice. Always rely on the original source.